Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Acute‐phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study

Open access
Salvarani, Carlo, Cantini, Fabrizio, Niccoli, Laura, Macchioni, Pierluigi, Consonni, Dario, Bajocchi, Gianluigi, Vinceti, Marco, Catanoso, Maria Grazia, Pulsatelli, Lia, Meliconi, Riccardo, Boiardi, Luigi · 2005 · Arthritis Care & Research

Abstract

Objective: To determine laboratory parameters that may be useful in identifying polymyalgia rheumatica (PMR) patients who require long‐term corticosteroid therapy. Methods: A prospective followup study of 94 consecutive untreated patients with PMR were assessed for relapse/recurrence for a mean of 39 months. This cohort represented all the patients diagnosed over a 4‐year period in 2 Italian secondary referral centers. Patients were monitored for clinical signs and symptoms, erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum interleukin‐6 (IL‐6). IL‐6 levels were also measured in 43 controls matched to the patients for age and sex. Results: The ESR was elevated in 91.5% of the patients prior to therapy initiation, as were CRP in 98.9% and serum IL‐6 in 92.6%. Forty‐seven (50.0%) patients had at least 1 relapse/recurrence during the followup period and 24 (25.5%) had at least 2. After 4 weeks of prednisone therapy, ESR was elevated in 13.2% patients, CRP in 41.9%, and serum IL‐6 in 37.2%. IL‐6 levels remained persistently elevated in 9.9% and CRP in 8.7% of patients during the first year of followup, whereas no patient had persistently elevated ESR. Persistently elevated CRP and IL‐6 levels were significantly associated with an increased risk of relapse/recurrence. In particular, patients with persistently elevated levels of IL‐6 during the first year of therapy had the highest relative risk. Conclusion: Despite the control of clinical symptoms, corticosteroids do not adequately control the inflammatory process in a subset of patients with PMR who have persistently elevated levels of CRP and IL‐6 and who have a higher risk of relapsing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.20901

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 160

Metadata

Authors
Salvarani, C., Cantini, F., Niccoli, L., Macchioni, P., Consonni, D., Bajocchi, G., Vinceti, M., Catanoso, M. G., Pulsatelli, L., Meliconi, R., & Boiardi, L.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2005-02-04
Volume
53
Issue
1
Pages
33-38
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W2020229760
Cited by
160
References
2
FWCI
5.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute‐phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study. https://app.cochat.ai/papers/10.1002/art.20901
The paper
Salvarani, C., Cantini, F., Niccoli, L., Macchioni, P., Consonni, D., Bajocchi, G., Vinceti, M., Catanoso, M. G., Pulsatelli, L., Meliconi, R., & Boiardi, L. (2005). Acute‐phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study. Arthritis Care & Research. https://doi.org/10.1002/art.20901

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.